logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Robert Walton McNutt, Jr

This inventor holds 9 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Delta Pharmaceuticals Ltd., Glaxo Wellcome Inc.. Active years: 1997-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Walton McNutt, Jr. Retrieved from https://idiyas.com/inventor/robert-walton-mcnutt-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 44.4

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 206(Granted Patents)


Company Filing History:

goldMedal3 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal2 out of 9 
 
Delta Pharmaceuticals Ltd.
 patents
bronzeMedal2 out of 281 
 
Glaxo Wellcome Inc.
 patents
4. 2 out of 10 
 
Versi Group, LLC
 patents

Years Active: 1997-2016

Loading Chart...
9 patents (USPTO):Explore Patents
1. 9296707 - Delta opioid receptor agonist compounds (2016-03-29),
2. 8865721 - Delta opioid receptor agonist compounds (2014-10-21),
3. 7129253 - Compounds (2006-10-31),
4. 6964977 - Oxindole derivatives (2005-11-15),
5. 6498176 - 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors (2002-12-24),
6. 6350747 - 3-(anilinomethylene) oxindoles (2002-02-26),
7. 6268391 - Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases (2001-07-31),
8. 5854249 - Opioid diarylmethylpiperazines and piperidines (1998-12-29),
9. 5658908 - Opioid diarylmethylpiperazines and piperdines (1997-08-19),

Title: The Innovations of Robert Walton McNutt, Jr.

Introduction

Robert Walton McNutt, Jr. is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of sexual dysfunction treatments. With a total of 9 patents to his name, McNutt has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents are the delta opioid receptor agonist compounds. These compositions and methods are designed for the treatment of sexual dysfunctions. They involve administering a pharmaceutical composition comprising a delta opioid receptor agonist in an amount effective to delay the onset of ejaculation during sexual stimulation. This innovative approach highlights McNutt's commitment to addressing complex medical issues.

Career Highlights

Throughout his career, McNutt has worked with prominent companies such as SmithKline Beecham Corporation and Glaxo Wellcome Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical science.

Collaborations

Some of his notable coworkers include Karen Elizabeth Lackey and Kwen-Jen Chang. Their collaborative efforts have likely played a role in the success of McNutt's inventions.

Conclusion

Robert Walton McNutt, Jr. is a distinguished inventor whose work in the pharmaceutical industry has led to significant advancements in the treatment of sexual dysfunctions. His innovative patents and collaborations reflect his dedication to improving medical outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…